This past fall, Hurricanes Irma and María struck Puerto Rico, leaving hundreds of thousands of people in their wake without the necessities for survival. More than three months after Hurricane María’s landfall, the island is still in crisis.
Earlier this month, we updated on the Food and Drug Administration’s efforts to mitigate ongoing IV saline shortages that resulted from, or were worsened by, the devastating impact of Hurricane María in Puerto Rico. We also provided some additional updates related to our continued efforts to help the island fully recover from this disaster.
As we enter the new year and pass the 100-day mark from when Hurricane María made landfall in Puerto Rico, we want to provide an update on the current recovery efforts, the state of existing drug shortages that resulted from the impact of the storm and our continued commitment to help the island fully recover.
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
